ANGLE plc (LON:AGL – Get Free Report) shares passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 10.73 ($0.14) and traded as low as GBX 9.50 ($0.12). ANGLE shares last traded at GBX 9.60 ($0.12), with a volume of 1,123,393 shares changing hands.
Analyst Upgrades and Downgrades
Separately, Berenberg Bank reiterated a “buy” rating and set a GBX 40 ($0.52) price target on shares of ANGLE in a research report on Wednesday, January 29th.
Check Out Our Latest Research Report on ANGLE
ANGLE Stock Down 7.7 %
About ANGLE
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.
Recommended Stories
- Five stocks we like better than ANGLE
- What is a Bond Market Holiday? How to Invest and Trade
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- The Most Important Warren Buffett Stock for Investors: His Own
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- Top Stocks Investing in 5G Technology
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.